As Bernie Focuses On Older Drug-Device Combos, Can Innovators Catch Their Breath?
AstraZeneca, GSK, Boehringer Ingelheim and Teva are targets of latest Senate Dems drug pricing investigation • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
